Clinical Trial Update: Vebreltinib for Advanced or Metastatic CCS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Vebreltinib in advanced or metastatic clear cell sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Sarcoma

Drugs mentioned

• Vebreltinib (vebreltinib)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Clear Cell Sarcoma (CCS) | Phase 2 | Status: RECRUITING